Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)
This study is currently recruiting participants.
Verified May 2012 by Therapeutic Concepts
Sponsor:
Therapeutic Concepts
Information provided by (Responsible Party):
Therapeutic Concepts
ClinicalTrials.gov Identifier:
NCT01608269
First received: May 25, 2012
Last updated: May 29, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2013 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |